MANNKIND CORP Shareholders' Equity
MANNKIND CORP (MNKD) had Shareholders' Equity of -$67.20 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent -$67.20M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$59.20M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$51.02M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$44.55M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$67.20M 10-Q · filed 2026-08-05 |
| 2026-03-31 | -$59.20M 10-Q · filed 2026-08-05 |
| 2025-12-31 | -$51.02M 10-Q · filed 2026-08-05 |
| 2025-09-30 | -$44.55M 10-Q · filed 2025-11-05 |
| 2025-06-30 | -$55.04M 10-Q · filed 2026-08-05 |
| 2025-03-31 | -$58.62M 10-Q · filed 2026-08-05 |
| 2024-12-31 | -$78.82M 10-Q · filed 2026-08-05 |
| 2024-09-30 | -$209.93M 10-Q · filed 2025-11-05 |
| 2024-06-30 | -$225.78M 10-Q · filed 2025-11-05 |
| 2024-03-31 | -$229.97M 10-Q · filed 2025-11-05 |
| 2023-12-31 | -$246.17M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$251.78M 10-Q · filed 2024-11-07 |
| 2023-06-30 | -$260.49M 10-Q · filed 2024-11-07 |
| 2023-03-31 | -$255.40M 10-Q · filed 2024-11-07 |
| 2022-12-31 | -$250.54M 10-K · filed 2026-02-26 |
| 2022-09-30 | -$237.68M 10-Q · filed 2023-11-07 |
| 2022-06-30 | -$247.06M 10-Q · filed 2023-11-07 |
| 2022-03-31 | -$232.06M 10-Q · filed 2023-11-07 |
| 2021-12-31 | -$209.35M 10-K · filed 2025-02-26 |
| 2021-09-30 | -$184.69M 10-Q · filed 2022-11-08 |
| 2021-06-30 | -$183.55M 10-Q · filed 2022-11-08 |
| 2021-03-31 | -$173.62M 10-Q · filed 2022-11-08 |
| 2020-12-31 | -$180.42M 10-K · filed 2024-02-27 |
| 2020-09-30 | -$186.42M 10-Q · filed 2021-11-09 |
| 2020-06-30 | -$179.71M 10-Q · filed 2021-11-09 |
| 2020-03-31 | -$198.05M 10-Q · filed 2021-11-09 |
| 2019-12-31 | -$190.53M 10-K · filed 2023-02-23 |
| 2019-09-30 | -$184.71M 10-Q · filed 2020-11-04 |
| 2019-06-30 | -$196.00M 10-Q · filed 2020-11-04 |
| 2019-03-31 | -$188.00M 10-Q · filed 2020-11-04 |
| 2018-12-31 | -$175.08M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$205.44M 10-Q · filed 2019-11-08 |
| 2018-06-30 | -$206.62M 10-Q · filed 2019-11-08 |
| 2018-03-31 | -$223.21M 10-Q · filed 2019-11-08 |
| 2017-12-31 | -$214.73M 10-K · filed 2020-02-25 |
| 2017-09-30 | -$251.01M 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$221.24M 10-Q · filed 2017-08-07 |
| 2017-03-31 | -$198.72M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$183.59M 10-K · filed 2019-02-26 |
| 2016-09-30 | -$238.69M 10-Q · filed 2016-11-09 |
| 2016-06-30 | -$366.58M 10-Q/A · filed 2016-08-10 |
| 2016-03-31 | -$373.46M 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$350.33M 10-K · filed 2019-02-26 |
| 2015-09-30 | -$124.57M 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$115.47M 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$97.03M 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$73.77M 10-K · filed 2018-02-27 |
| 2014-09-30 | -$40.68M 10-Q · filed 2014-11-10 |
| 2014-06-30 | -$46.38M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $17.54M 10-Q · filed 2014-05-12 |
| 2013-12-31 | -$30.71M 10-K · filed 2017-03-16 |
| 2013-09-30 | -$167.72M 10-Q · filed 2013-11-12 |
| 2013-06-30 | -$152.36M 10-Q · filed 2013-08-09 |
| 2013-03-31 | -$146.81M 10-Q · filed 2013-05-10 |
| 2012-12-31 | -$110.68M 10-K · filed 2016-03-15 |
| 2012-09-30 | -$276.25M 10-Q · filed 2012-11-09 |
| 2012-06-30 | -$244.38M 10-Q · filed 2012-08-09 |
| 2012-03-31 | -$277.39M 10-Q · filed 2012-05-10 |
| 2011-12-31 | -$313.65M 10-K · filed 2015-03-02 |
| 2011-09-30 | -$280.81M 10-Q · filed 2011-11-04 |
| 2011-06-30 | -$245.38M 10-Q · filed 2011-08-04 |
| 2010-12-31 | -$185.53M 10-K · filed 2014-03-03 |
| 2009-12-31 | -$59.22M 10-K · filed 2014-03-03 |
| 2008-12-31 | $86.73M 10-K · filed 2014-03-03 |
| 2007-12-31 | $364.10M 10-K · filed 2014-03-03 |
| 2006-12-31 | $383.49M 10-K · filed 2014-03-03 |
| 2005-12-31 | $206.98M 10-K · filed 2014-03-03 |
| 2004-12-31 | $150.36M 10-K · filed 2014-03-03 |
| 2003-12-31 | $111.58M 10-K · filed 2014-03-03 |
| 2002-12-31 | $90.77M 10-K · filed 2014-03-03 |
| 2001-12-31 | $235.02M 10-K · filed 2014-03-03 |
| 2000-12-31 | $31.89M 10-K · filed 2014-03-03 |
| 1999-12-31 | -$746.00K 10-K · filed 2014-03-03 |
| 1998-12-31 | $3.40M 10-K · filed 2014-03-03 |
| 1997-12-31 | -$7.37M 10-K · filed 2014-03-03 |
| 1996-12-31 | -$5.48M 10-K · filed 2014-03-03 |
| 1995-12-31 | -$3.11M 10-K · filed 2014-03-03 |
| 1994-12-31 | -$707.00K 10-K · filed 2014-03-03 |
| 1994-02-28 | -$908.00K 10-K · filed 2014-03-03 |
| 1993-02-28 | -$278.00K 10-K · filed 2014-03-03 |
| 1992-02-29 | -$11.00K 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |